Clinical experience of levetiracetam monotherapy for adults with epilepsy: 1-year follow-up study

Seizure

Volumn 14, Issue 2, 2005, Pages 139-142

  Alsaadi, Taoufik M ^a   Shatzel, Alan ^a   Marquez, Anna Vinter ^a   Jorgensen, Julie ^a   Farias, Sarah ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Levetiracetam; Monotherapy; Partial seizures

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROATE SEMISODIUM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EXPERIENCE; FEMALE; FOCAL EPILEPSY; FOLLOW UP; HEMATOLOGIC DISEASE; HUMAN; MALE; MONOTHERAPY; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; ELECTROENCEPHALOGRAPHY; EPILEPSIES, PARTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PIRACETAM; RETROSPECTIVE STUDIES; VIDEO RECORDING;

EID: 13444269601     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2004.12.006     Document Type: Article

References (12)

1. R. Mattson J. Cramer J. Collins et al. Comparison of Carbamazepine, Phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures N Engl J Med 31 3 1985 145-151
2. P. Kwan M. Brodie Early identification of refractory epilepsy N Engl J Med 342 5 2000 314-319
3. J.J. Cereghino V. Biton B. Abou-Khalil et al. Levetiracetam for partial seizures: Results of a double blind randomized clinical trial Neurology 35 2000 236-242
4. S.D. Shorvon A. Lowenthal D. Janz et al. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures Epilepsia 41 2000 1179-1186
5. E. Ben-Menachem U. Falter Efficacy and tolerability of Levetiracetam 3000 mg in patients with refractory partial seizures: A multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group Epilepsia 41 2000 1276-1283
6. P.N. Patsalos Pharmacokinetic profile of LEV: Toward ideal characteristics Pharmacol Ther 85 2000 77-85
7. T.M. Alsaadi C. Thieman E.E. Zusman Levetiracetam monotherapy for adults with localization-related epilepsy Epilepsy Behav 3 5 2002 471-474
8. K. Krakow M. Walker C. Otoul J.W.A.S. Sander Long term continuation of levetiracetam in patients with refractory epilepsy Neurology 56 2001 1772-1774
9. E. Ben-Menachem E. Gilland Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy Seizure 12 3 2003 131-135
10. T. Betts H. Yarrow L. Greenhill M. Barrett Clinical experience of marketed levetiracetam in an epilepsy clinic - a one-year follow-up study Seizure 12 3 2003 136-140
11. T.A. Ketter R. Post W.H. Theodore Positive and negative psychotropic effects of antiepileptic drugs in patients with seizure disorder Neurology 53 5 Suppl. 2 1999 S53-S67
12. A.T. Berg J. Langfitt S. Shinnar et al. How long does it take for partial epilepsy to become intractable? Neurology 60 2003 186-190